Cargando…

Do we now have a relevant animal model for breast cancer?

Detalles Bibliográficos
Autores principales:	Gusterson, Barry, Howard, Beatrice, Crook , Tim, Tennent, Barbara
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 1999
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138500/ https://www.ncbi.nlm.nih.gov/pubmed/11250672 http://dx.doi.org/10.1186/bcr2

Ejemplares similares

Early goal-directed therapy: what do we do now?
por: Levy, Mitchell M
Publicado: (2014)

Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?
por: Sainathan, Sandeep, et al.
Publicado: (2021)

Do we still need animals? Surveying the role of animal‐free models in Alzheimer’s and Parkinson’s disease research
por: Aerts, Liesbeth, et al.
Publicado: (2022)

Bone-Targeted Agents in Breast Cancer: Do We Now Have All the Answers?
por: Ottewell, Penny, et al.
Publicado: (2019)

5-α reductase inhibitors and prostate cancer prevention: where do we turn now?
por: Hamilton, Robert J, et al.
Publicado: (2011)

Drugs for malaria elimination: what do we have now and what do we need?
por: Shanks, Dennis
Publicado: (2014)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Do We Have a Channel Solution for ALS?
por: de Carvalho, Mamede
Publicado: (2015)

Ventilator-associated tracheobronchitis: where are we now?
por: Nseir, Saad, et al.
Publicado: (2014)

Genetic counseling globally: Where are we now?
por: Ormond, Kelly E., et al.
Publicado: (2018)

World Health Organization AWaRe framework for antibiotic stewardship: Where are we now and where do we need to go? An expert viewpoint
por: Mudenda, Steward, et al.
Publicado: (2023)

Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease?
por: Crook, David
Publicado: (2001)

We need people’s WHO to solve vaccine inequity, and we need it now
por: Kim, Hani
Publicado: (2021)

Glargine and Cancer: Can We Now Suggest Closure?
por: Owens, David R.
Publicado: (2012)

Neoadjuvant treatment of rectal cancer: where are we now?
por: Kalyan, Aparna, et al.
Publicado: (2016)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Commentary: What do we still have to learn from surgery?
por: Belluschi, Igor, et al.
Publicado: (2021)

Anti-cytokine therapy in fibrosing alveolitis: where are we now?
por: Millar, Ann
Publicado: (2000)

Medically Complex Living Kidney Donors: Where Are We Now?
por: Textor, Stephen C.
Publicado: (2019)

Polygenic risk scores for complex diseases: where are we now?
por: Loh, Marie, et al.
Publicado: (2023)

Conduction System Pacing: Where Are We Now?
por: Niazi, Imran
Publicado: (2022)

Mobile Phones, Brain Tumors, and the Interphone Study: Where Are We Now?
por: Swerdlow, Anthony J., et al.
Publicado: (2011)

The looming pandemic of COVID-19: What therapeutic options do we have now?
por: Afsar, Nasir Ali
Publicado: (2020)

Commentary: Managing catastrophic antiphospholipid syndrome—do we have a way out?
por: Hirji, Sameer A., et al.
Publicado: (2021)

Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007)

Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?
por: Rockman, Steven, et al.
Publicado: (2020)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

Animal Models of Neurological Disorders: Where Are We Now?
por: Panthi, Sandesh, et al.
Publicado: (2023)

Wnt signaling in breast cancer: have we come full circle?
por: Brown, Anthony MC
Publicado: (2001)

What Do We Want? INHIBITION. When Do We Want it? NOW
por: Maguire, Jamie L.
Publicado: (2019)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Can We See Clearly Now? Computed Tomography for Bronchiolitis Obliterans Syndrome Prognostication
por: Trindade, Anil J.
Publicado: (2023)

The Patients We Have to See
por: Irwin, Kelly E.
Publicado: (2017)

Pulse oximeter as a sensor of fluid responsiveness: do we have our finger on the best solution?
por: Monnet, Xavier, et al.
Publicado: (2005)

When should we start renal-replacement therapy in critically ill patients with acute kidney injury: do we finally have the answer?
por: Bagshaw, Sean M., et al.
Publicado: (2021)

Changes in the Multiple Sclerosis Treatment Paradigm. What Do We Do Now and What Were We Doing Before?
por: Alonso, Ricardo, et al.
Publicado: (2018)

Breast cancer risk perception: what do we know and understand?
por: Hopwood, Penelope
Publicado: (2000)

Why do we need better omics in the breast cancer care?
por: Gertych, Arkadiusz, et al.
Publicado: (2021)

Medical Staff Responses to COVID-19 ‘Data’: Have We Misplaced Our Skeptic's Eye?
por: Meisenberg, Barry R.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n14qt6r11pq99tte0d4s0f08bq